A study has shown that people who live in an environment with lots of greenery, parks and water have a lower risk of developing neurodegenerative diseases such as Alzheimer's and Parkinson's. This relationship still holds when factors such as income and air quality are taken into account
A new method enables the detection of the onset of Parkinson's disease before the onset of brain damage and symptoms such as tremors. A protein in the brain water can indicate early on Parkinson's. Experts describe the procedure as a "game changer" for the diagnosis, research and treatment of Parkinson's. The findings are expected to have implications for new therapies.
The first tests of this promising therapy in people with Parkinson's, in which the diseased brain cells are replaced by healthy nerve cells, will start as early as January 2023. Eight brave people from England and Sweden will be the first people to have this new method tested on them. And if everything goes well, there is a very good chance that stem cell therapy will be rolled out in five years.
Parkinson's and creativity are closely related, as many have already noticed. Conversely, we didn't all become van Goghs and Frida Kahlos just because we had Parkinson's disease. What an idea! However, there is no denying that the desire to express oneself artistically and creatively remains strong among some people with Parkinson's.
Stacey Macaluso from the USA, for example, has launched a platform that offers new exercise offers weekly, either as webinars or videos, free of charge for people with Parkinson's.
But she does not leave it at that, but combines her offer with political demands. She explains the connection between the Parkinson's diagnosis and environmental toxins. Just recently it emerged that the US appears to be importing fertilizers that are already on the US red list from other countries and using them in agriculture. Stacey has made it his mission to draw attention to this scandal and collect signatures and change the law. She says: “My community is working on these laws and sharing resources. We're not just a gym. We want to help change the future of Parkinson's disease.
The Angry Professor's Appeal
dr Ray Dorsey is Professor of Neurology and Director of the Center for Human Experimental Therapeutics at the University of Rochester in the USA. And he is angry and disappointed in his colleagues.
The trigger is an international Parkinson's congress that was held in Madrid a few days ago and was attended by Dr. Dorsey attended. The most recent studies presented there focused mainly on the genetic cause of Parkinson's.
I feel for dr. Ray Dorsey. You're probably wondering why this is the cause of an outburst from one of the world's leading neurologists and Parkinson's experts. Genetic research in Parkinson's has made great strides.
The fatal thing is that most researchers concentrate on a topic that only
Affects 17 percent of people with Parkinson's disease.
I wrote this post a long time ago and didn't have the courage to publish it. Today is a good day for that, as surely any other would have been. Here we go: In one issue of online magazine Parkinson's Life it was reported that the crew of a Ryanair flight in the UK refused to let a passenger with Parkinson's on board because they thought he was drunk.
This case caused a huge outrage on British social media and I wonder how the public in Germany would have reacted to such a case. In the worst case, it would probably not have been made public and the person concerned would have had to deal with the problem on their own (in the best case there would have been a small newspaper report about it). It is not uncommon for Parkinson's to be confused with alcoholism. At first glance, the symptoms are very similar (except for the missing flag). Then there is whispering or looks, but nobody thinks of addressing the person: "What's the matter with you? Do you have Parkinson's?"
"Alpha-synuclein-binding antibodies in Parkinson's are a disappointment"
This is how a statement by the German Society for Neurology (DGN) can be summed up.
Those affected, like me, who have been involved in research and development in the fight against Parkinson's in recent years, have not been able to avoid the protein alpha-synuclein.
Today I read an interesting article in Bayer's newsletter. Yes, that's exactly what I mean, the pharmaceutical giant Bayer. Now you're getting suspicious, aren't you? The article is about a groundbreaking, groundbreaking advance in Parkinson's therapy. Probably a new drug that only works on the surface, costs a lot of money and just takes money out of people's pockets.
How non-drug tricks can help you run better
It sometimes happens that while walking, one of my feet takes on a life of its own and starts to twist. My muscles get stiff, my toes curl up and I can't move with the best will in the world. There is no good coaxing, no stretching, no nothing, except standing still, breathing consciously and relaxing.
What many do not know, however, is that research now assumes that Parkinson's is not just a single disease. Rather, we are dealing with a variety of neurological disorders crammed under one Parkinson's umbrella. Welcome to the Parkinson's party!